BIO-key International, Inc.

How big is BIO-key International, Inc.?

As of Jun 18, BIO-key International, Inc. has a market capitalization of 4.69 million, with net sales of 6.35 million and a net profit of -4.72 million over the last four quarters. Shareholder's funds are 3.77 million, and total assets amount to 8.62 million as of Dec 24.

Market Cap: As of Jun 18, BIO-key International, Inc. has a market capitalization of 4.69 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the sum of Net Sales is 6.35 million, while the sum of Net Profit is -4.72 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the Shareholder's Funds amount to 3.77 million, and the Total Assets are 8.62 million.

What does BIO-key International, Inc. do?

BIO-key International, Inc. develops fingerprint biometric identification and identity verification technologies, operating in the micro-cap market with recent net sales of $2 million and a market cap of $4.69 million. The company reported a net profit loss of $1 million for the most recent quarter.

Overview:<BR>BIO-key International, Inc. develops and markets fingerprint biometric identification and identity verification technologies within the Computers - Software & Consulting industry, and it operates in the micro-cap market segment.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 2 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -1 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 4.69 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.29 <BR>Return on Equity: -62.57% <BR>Price to Book: 0.62<BR><BR>Contact Details:<BR>Address: 3349 State Route 138 Ste E, WALL TOWNSHIP NJ: 07719-9671 <BR>Tel: 1 732 3591100 <BR>Fax: 1 651 6870515 <BR>Website: http://www.bio-key.com/

Should I buy, sell or hold BIO-key International, Inc.?

Who are in the management team of BIO-key International, Inc.?

As of March 2022, the management team of BIO-key International, Inc. includes Chairman and CEO Michael DePasquale, Co-Chairman Kwok Fong Wong, and several independent directors: Manny Alia, Thomas Bush, Thomas Gilley, Pieter Knook, and Robert Michel. They oversee the company's strategic direction and operations.

As of March 2022, the management team of BIO-key International, Inc. includes:<BR><BR>- Mr. Michael DePasquale, who serves as the Chairman of the Board and Chief Executive Officer.<BR>- Mr. Kwok Fong Wong, who is the Co-Chairman of the Board.<BR>- Mr. Manny Alia, who is a Director.<BR>- Mr. Thomas Bush, who is an Independent Director.<BR>- Mr. Thomas Gilley, who is also an Independent Director.<BR>- Mr. Pieter Knook, who serves as an Independent Director.<BR>- Mr. Robert Michel, who is another Independent Director. <BR><BR>This team is responsible for guiding the company's strategic direction and operations.

Is BIO-key International, Inc. technically bullish or bearish?

As of August 13, 2025, BIO-key International, Inc. is in a mildly bearish trend, with a year-to-date return of -53.35%, significantly underperforming the S&P 500's 12.22%.

As of 13 August 2025, the technical trend for BIO-key International, Inc. has changed from sideways to mildly bearish. The current stance is bearish, primarily driven by the daily moving averages indicating a mildly bearish trend. While the weekly MACD, KST, and OBV show mildly bullish signals, the overall monthly indicators, including the Bollinger Bands and Dow Theory, lean towards a bearish outlook. <BR><BR>In terms of performance, the stock has underperformed significantly compared to the S&P 500, with a year-to-date return of -53.35% versus the S&P 500's 12.22%, and a 1-year return of -34.07% compared to the S&P 500's 17.14%.